When a child goes home, the data goes dark.
Lumily is a pediatric visibility platform in development
A wearable, a caregiver app, and a clinician-facing layer designed to learn each child's own baseline at home and surface the changes that deserve attention.
01THE GAP
The post-discharge blind spot
- children have surgery each year
- 4Mchildren have surgery each year
- children are readmitted within 30 days
- 125K+children are readmitted within 30 daysMarkham et al. reviewed 125,000+ pediatric 30-day readmissions;
- the post-discharge window when families are watching alone
- 30 daysthe post-discharge window when families are watching alone
Research suggests a meaningful share may be preventable.
02THE APPROACH
Visibility built around each child, not population averages
A baseline of one
Every child runs different. Lumily is designed to learn each child's own patterns, so change is measured against that child, not a chart of averages.
Signals that agree
Our patent-pending approach looks for agreement across multiple signals before surfacing a change. It is designed to respect clinicians' time and families' nerves.
Made for the workflow
For care teams, Lumily is designed to answer three questions fast: what changed, when, and how far from this child's normal. A summary, not a firehose.
03EVIDENCE
Evidence before everything
We are taking a clinical-first path: validation before launch. Our first feasibility study, focused on children recovering at home after higher-risk surgery, is now in design with academic and clinical partners.
Lumily is an investigational, pre-market platform. It has not been reviewed by the FDA and makes no diagnostic claims. Today, our job is building the evidence.
04ABOUT
Why I’m Building Lumily
As a patient, parent, and healthcare product builder, I’ve seen how often important health context gets scattered between specialists, hospital visits, wearables, and daily life.
After 10+ years building healthcare enterprise software, I’m developing Lumily to explore how home health signals and caregiver observations can be organized into clearer context for families and care teams.
Lumily is currently in development and has not been reviewed, cleared, or approved by the FDA. It is not intended to diagnose, treat, cure, or prevent disease.
05LISTENING
We are in our listening phase. Join it.
Clinicians and researchers
If you live the post-discharge handoff, in surgery, hospital medicine, infectious disease, quality, or care management, we want 20 minutes of your reality. Not a pitch. Questions.
Hospital and health plan leaders
We are studying how post-discharge visibility fits quality goals, budgets, and value-based care for children. Teach us how it really works.
Partners and investors
We are non-dilutive-first and relationship-driven. If pediatric health is your thesis, we would rather meet you early than pitch you late.
PARENTS
When pilots near, Lumily will open a founding family list. Leave your email and we will reach out.
We will only email you about Lumily. No sharing, no spam, unsubscribe anytime.